Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bella Ungar
Letter: Double-Dose Intensification-A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab. Authors Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Letter: Double-Dose Intensification - A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab-Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Reassuringly Normal Response to ACTH in Children Treated With Swallowed Topical Corticosteroids for Eosinophilic Oesophagitis - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Dose-Response Analysis Revealed Closer Relationship Between Obesity and Perioperative Outcomes in Patients After Liver Transplantation-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prednisolone Response in Patients With COPD * Authors' Reply
Thorax
Pulmonary
Respiratory Medicine
Authors Reply Letter to the Reviewers
